Bicycle Therapeutics plc (BCYC) Financials

BCYC Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 595.3 million 224.4 million
2023-09-30 638.7 million 222.7 million
2023-06-30 454.2 million 234.1 million
2023-03-31 428.8 million 185.6 million

BCYC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -47.3 million 7.8 million
2023-09-30 -1.5 million 7.4 million
2023-06-30 33.8 million 8.2 million
2023-03-31 -48.5 million 9.0 million

BCYC Net Income

No data available :(

BCYC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 526.4 million - 14.3 million
2023-09-30 572.1 million - 15.1 million
2023-06-30 340.4 million - 16.6 million
2023-03-31 293.8 million - 19.0 million

BCYC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 42.4 million
2023-09-30 39.6 million
2023-06-30 30.2 million
2023-03-31 30.0 million

BCYC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 51000 44.7 million 15.1 million -
2023-09-30 502000 39.9 million 15.6 million -
2023-06-30 277000 39.7 million 15.2 million -
2023-03-31 2.1 million 32.2 million 14.5 million -

BCYC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 5.3 million 1.7 million
2023-09-30 5.4 million 1.7 million
2023-06-30 11.4 million 1.7 million
2023-03-31 4.9 million 1.6 million

BCYC

Price: $24.69

52 week price:
12.54
28.91

Earnings Per Share: -5.08 USD

P/E Ratio: -3.47

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 365200

Market Capitalization: 862.9 million

Links: